KH

Kaitou Hanrun Capital

Description

Kaitou Hanrun Capital is an Investment firm.

Investor Profile

Kaitou Hanrun Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series C (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kaitou Hanrun Capital frequently co-invest with?

Boquan Capital
Asia, Shanghai, China, Hongkou
Co-Investments: 1
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
PS
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
FTZ Fund
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1
Oriental Fortune Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by Kaitou Hanrun Capital?

Ark Biosciences

Shanghai, Shanghai, China

Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CJan 22, 2021
Amount Raised: $86,000